Clinical Trial Update: Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and preliminary activity of combining everolimus with cytarabine and daunorubicin in relapsed acute myeloid leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Everolimus (everolimus)

Snippet

Sponsor: Institut de Recherche Clinique sur les Cancers et le Sang | Conditions: Leukemia | Phase 1 | Status: UNKNOWN